Delivery Order SPE2DB22D3401-SPE2DB25FT5LZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,224.10 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in a 90-count package. This competitive award, issued on August 11, 2025, with a completion date of August 12, 2025, represents a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $2,442.00 delivery order to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets (90-count units) under a firm fixed-price contract. The award, issued on July 17, 2025, is scheduled for completion by July 18, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location in the same city....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Letrozole 2.5mg (90-count supply) valued at $6,490.08 under a firm fixed price contract type. The award was made on July 24, 2025, with an ultimate completion date of the same day, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $2,026.98 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Letrozole is a commonly prescribed aromatase inhibitor used in the treatment of hormone receptor-positive breast cancer in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Letrozole 2.5 mg tablets (90-count units) on September 11, 2025, with a ceiling value of $1,448.81 and an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.29 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in a 30-count package. This competitive award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units at a firm fixed price of $1,271.50. This is a non-set-aside competitively awarded contract with an ultimate completion date of August 14, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,172.86 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,116.30 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with a completion...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30 units, with a ceiling value of $4,624.30. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5LZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,117.34 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in a quantity of 90s. This firm fixed-price delivery order, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded with no set-aside designation. The products will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Letrozole is an aromatase inhibitor commonly used in hormone therapy treatments, reflecting the breadth of pharmaceutical products that AmerisourceBergen supplies through federal medical procurement channels. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 8/5/25 |